File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Management of dyslipidemia in the metabolic syndrome

TitleManagement of dyslipidemia in the metabolic syndrome
Authors
Issue Date2007
PublisherBentham Science Publishers Ltd. The Journal's web site is located at http://www.bentham.org/cdtchd
Citation
Cardiovascular And Hematological Disorders - Drug Targets, 2007, v. 7 n. 2, p. 99-108 How to Cite?
AbstractThe metabolic syndrome consists of a clustering of metabolic derangements that cause the affected individual to have an increased risk for developing cardiovascular disease. Dyslipidemia is an important component of the metabolic syndrome and is included in all the definitions of the metabolic syndrome published by different international committees to identify individuals with the metabolic syndrome. Atherogenic dyslipidemia in the metabolic syndrome comprises of hypertriglyceridemia, low levels of high-density lipoprotein cholesterol and a preponderance of small dense low-density lipoprotein particles. The pathogenesis of dyslipidemia in the metabolic syndrome will be reviewed and the roles of therapeutic lifestyle modification and drug therapies in the treatment of dyslipidemia will be discussed. © 2007 Bentham Science Publishers Ltd.
Persistent Identifierhttp://hdl.handle.net/10722/76893
ISSN
2015 SCImago Journal Rankings: 0.718
References

 

DC FieldValueLanguage
dc.contributor.authorTan, KCBen_HK
dc.date.accessioned2010-09-06T07:26:03Z-
dc.date.available2010-09-06T07:26:03Z-
dc.date.issued2007en_HK
dc.identifier.citationCardiovascular And Hematological Disorders - Drug Targets, 2007, v. 7 n. 2, p. 99-108en_HK
dc.identifier.issn1871-529Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/76893-
dc.description.abstractThe metabolic syndrome consists of a clustering of metabolic derangements that cause the affected individual to have an increased risk for developing cardiovascular disease. Dyslipidemia is an important component of the metabolic syndrome and is included in all the definitions of the metabolic syndrome published by different international committees to identify individuals with the metabolic syndrome. Atherogenic dyslipidemia in the metabolic syndrome comprises of hypertriglyceridemia, low levels of high-density lipoprotein cholesterol and a preponderance of small dense low-density lipoprotein particles. The pathogenesis of dyslipidemia in the metabolic syndrome will be reviewed and the roles of therapeutic lifestyle modification and drug therapies in the treatment of dyslipidemia will be discussed. © 2007 Bentham Science Publishers Ltd.en_HK
dc.languageengen_HK
dc.publisherBentham Science Publishers Ltd. The Journal's web site is located at http://www.bentham.org/cdtchden_HK
dc.relation.ispartofCardiovascular and Hematological Disorders - Drug Targetsen_HK
dc.subject.meshAsia - epidemiologyen_HK
dc.subject.meshCholesterol Ester Transfer Proteins - antagonists & inhibitorsen_HK
dc.subject.meshCholesterol, HDL - deficiencyen_HK
dc.subject.meshCholesterol, LDL - blooden_HK
dc.subject.meshCombined Modality Therapyen_HK
dc.subject.meshDyslipidemias - drug therapy - epidemiology - etiology - therapyen_HK
dc.subject.meshHumansen_HK
dc.subject.meshHypertriglyceridemia - complications - epidemiology - therapyen_HK
dc.subject.meshHypolipidemic Agents - therapeutic useen_HK
dc.subject.meshMetabolic Syndrome X - complications - epidemiology - therapyen_HK
dc.titleManagement of dyslipidemia in the metabolic syndromeen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1871-529X&volume=7&spage=99&epage=108. Review&date=2007&atitle=Management+of+dyslipidemia+in+the+metabolic+syndromeen_HK
dc.identifier.emailTan, KCB:kcbtan@hku.hken_HK
dc.identifier.authorityTan, KCB=rp00402en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.pmid17584044-
dc.identifier.scopuseid_2-s2.0-34347394984en_HK
dc.identifier.hkuros129960en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-34347394984&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume7en_HK
dc.identifier.issue2en_HK
dc.identifier.spage99en_HK
dc.identifier.epage108en_HK
dc.publisher.placeNetherlandsen_HK
dc.identifier.scopusauthoridTan, KCB=8082703100en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats